EcoDrugPlus

Ensembl ID : ENSOMYG00000017649
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSOMYG00000005316
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSOMYG00000005192
Gene Symbol: -
Cross references: -
262 Possible Orthologues:

Ensembl ID : ENSOMYG00000005110
Gene Symbol: -
Cross references: -
303 Possible Orthologues:

Ensembl ID : ENSOMYG00000018408
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000005055
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSOMYG00000004357
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSOMYG00000019025
Gene Symbol: -
Cross references: -
220 Possible Orthologues:

Ensembl ID : ENSOMYG00000019072
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSOMYG00000003842
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOMYG00000003694
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOMYG00000019217
Gene Symbol: -
Cross references: -
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).